{"id":"felbinac-trometamol-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal irritation"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL413965","moleculeType":"Small molecule","molecularWeight":"212.25"},"_fixedAt":"2026-03-30T12:58:52.757114","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Felbinac is a propionic acid derivative NSAID that works by inhibiting both COX-1 and COX-2 enzymes, thereby decreasing the production of pro-inflammatory prostaglandins. The trometamol salt formulation is designed to enhance solubility and bioavailability for parenteral administration. This mechanism provides analgesic, anti-inflammatory, and antipyretic effects.","oneSentence":"Felbinac trometamol is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:12:21.010Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute pain and inflammation"},{"name":"Postoperative pain"},{"name":"Musculoskeletal pain conditions"}]},"_fixedFields":["pubmed(2)"],"trialDetails":[{"nctId":"NCT04526132","phase":"PHASE3","title":"A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China","status":"COMPLETED","sponsor":"Shijiazhuang Yiling Pharmaceutical Co. Ltd","startDate":"2021-04-25","conditions":"Pain","enrollment":306},{"nctId":"NCT05297669","phase":"PHASE3","title":"A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China","status":"COMPLETED","sponsor":"Shijiazhuang Yiling Pharmaceutical Co. Ltd","startDate":"2021-07-23","conditions":"Pain","enrollment":264},{"nctId":"NCT03872830","phase":"PHASE2","title":"A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China","status":"COMPLETED","sponsor":"Shijiazhuang Yiling Pharmaceutical Co. Ltd","startDate":"2019-03-27","conditions":"Pain","enrollment":165},{"nctId":"NCT03617510","phase":"PHASE1","title":"A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China","status":"COMPLETED","sponsor":"Shijiazhuang Yiling Pharmaceutical Co. Ltd","startDate":"2018-07-10","conditions":"Pain","enrollment":48},{"nctId":"NCT03235778","phase":"PHASE1","title":"A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China","status":"COMPLETED","sponsor":"Yiling Pharmaceutical Inc.","startDate":"2017-07-17","conditions":"Healthy","enrollment":58}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"recentPublications":[],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["4-Biphenylacetic Acid Trishydroxymettiylaminometnane","4-Biphenylacetic Acid"],"phase":"phase_3","status":"active","brandName":"Felbinac Trometamol Injection","genericName":"Felbinac Trometamol Injection","companyName":"Shijiazhuang Yiling Pharmaceutical Co. Ltd","companyId":"shijiazhuang-yiling-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Felbinac trometamol is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation. Used for Acute pain and inflammation, Postoperative pain, Musculoskeletal pain conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":4,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}